SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-050131
Filing Date
2013-02-12
Accepted
2013-02-12 07:08:55
Documents
3
Period of Report
2013-02-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d483036d8k.htm 8-K 17661
2 EX-99.1 d483036dex991.htm EX-99.1 139428
3 GRAPHIC g483036ex99_1pg1.jpg GRAPHIC 16771
  Complete submission text file 0001193125-13-050131.txt   181505
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 13594286
SIC: 2834 Pharmaceutical Preparations